COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Control group: 50 patients receive routine interventions according to the instructions of the Ministry of Health for 1 weeks. Intervention 2: Intervention group: 50 patients receive he
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients who require hospitalization based on national guidelines for diagnosis and treatment of COVID-19 and need to start drugs. 18 to 75 years of age for both sexes The patient's ability to fill out an informed consent form to enter the study
Exclusion criteria
Exclusion criteria: Pregnancy and lactation History of allergy to any of the components of the herbal product The patient's inability to take oral form The patients with serious underlying disease at the same time, including high blood pressure, heart disease, lung disease, cerebral disease, diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Temperature. Timepoint: 0-1-2-3-4-5-6-7 days after starting intervention. Method of measurement: Mercury thermometer.;Cough severity. Timepoint: 1th and 7th dady after starting intervention. Method of measurement: cough severity score 1-4.;Respiratory rate. Timepoint: 0-1-2-3-4-5-6-7 days after starting intervention. Method of measurement: Counting the number of breaths per minute.;Dyspnea severity. Timepoint: 0-1-2-3-4-5-6-7 days after starting intervention. Method of measurement: Dyspnea severity score 1-4.;O2 saturation percentage. Timepoint: pulse oximetry at baseline, 1-2-3-4-5-6-7 days after starting intervention. Method of measurement: pulse oximeter.;White blood cell count. Timepoint: baseline and day 7 after starting intervention. Method of measurement: WBC counting under the microscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamid Aboosaeidi
Kerman University of Medical Sciences
Outcome results
None listed